Envoy Medical, Inc.

Envoy Medical, Inc. (Nasdaq: COCH) is a hearing health medical device company that completed its de-SPAC merger with Anzu Special Acquisition Corp I, sponsored by Anzu Partners, in 2023. The blank-check vehicle held its IPO in 2021, targeting the medical technology sector with a focus on implantable hearing solutions. Envoy Medical develops the Acclaim fully implanted cochlear implant and the Esteem implantable hearing device, competing in the specialized audiology implant market. The company filed an 8-K with the SEC on May 11, 2026, under accession number 0001213900-26-054185. For full filing history, deal analytics, and real-time SPAC data on COCH and hundreds of other vehicles, sign up for SpacDesk at spacdesk.com.